Fmr LLC Acquires 830 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

Fmr LLC lifted its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 13.6% in the third quarter, Holdings Channel.com reports. The institutional investor owned 6,940 shares of the exchange traded fund’s stock after acquiring an additional 830 shares during the period. Fmr LLC’s holdings in SPDR S&P Biotech ETF were worth $686,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also modified their holdings of the business. Envestnet Portfolio Solutions Inc. acquired a new stake in SPDR S&P Biotech ETF in the second quarter valued at approximately $290,000. Fifth Third Bancorp boosted its holdings in shares of SPDR S&P Biotech ETF by 3.4% during the 2nd quarter. Fifth Third Bancorp now owns 118,303 shares of the exchange traded fund’s stock valued at $10,968,000 after acquiring an additional 3,922 shares in the last quarter. Atria Wealth Solutions Inc. grew its position in SPDR S&P Biotech ETF by 56.1% during the 2nd quarter. Atria Wealth Solutions Inc. now owns 16,597 shares of the exchange traded fund’s stock worth $1,539,000 after acquiring an additional 5,962 shares during the last quarter. Koa Wealth Management LLC grew its position in SPDR S&P Biotech ETF by 2.4% during the 2nd quarter. Koa Wealth Management LLC now owns 10,084 shares of the exchange traded fund’s stock worth $935,000 after acquiring an additional 232 shares during the last quarter. Finally, SOL Capital Management CO increased its holdings in SPDR S&P Biotech ETF by 0.5% in the 2nd quarter. SOL Capital Management CO now owns 31,940 shares of the exchange traded fund’s stock worth $2,961,000 after purchasing an additional 174 shares in the last quarter.

SPDR S&P Biotech ETF Trading Down 0.2 %

SPDR S&P Biotech ETF stock opened at $94.59 on Wednesday. The stock has a 50-day moving average price of $97.96 and a two-hundred day moving average price of $97.21. SPDR S&P Biotech ETF has a 12 month low of $81.14 and a 12 month high of $105.47. The company has a market capitalization of $7.21 billion, a PE ratio of 11.47 and a beta of 1.11.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.